Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency

详细信息    查看全文

• 作者：Jennifer Wang ; MBBS^a ; ^b ; ¹ ; Juliana Andrici ; MBBS ; MPhil^a ; ^b ; ^c ; ¹ ; Loretta Sioson ; BSc^a ; Adele Clarkson ; BSc^a ; ^b ; Amy Sheen ; BSc^a ; Mahtab Farzin ; MD ; FRCPA^a ; Christopher W. Toon ; MBBS ; FRCPA^a ; ^c ; ^d ; John Turchini ; MBBS^a ; ^b ; ^c ; Anthony J. Gill ; MD ; FRCPA^a ; ^b ; ^c ; ^{affgill@med.usyd.edu.au" class="auth_mail" title="E-mail the corresponding author}
• 关键词：INI1 ; Colorectal carcinoma ; SMARCB1 ; BRAFV600E ; Mismatch repair deficiency
• 刊名：Human Pathology
• 出版年：2016
• 出版时间：September 2016
• 年：2016
• 卷：55
• 期：Complete
• 页码：83-90
• 全文大小：2092 K

文摘

SMARCB1 is a tumor suppressor gene that encodes for the protein INI1. SMARCB1 is commonly inactivated and INI1 correspondingly shows loss of expression in a range of malignant neoplasms including rhabdoid tumors, renal medullary carcinomas, and epithelioid sarcomas. Loss of INI1 expression has recently been reported in occasional gastrointestinal adenocarcinomas. We sought to investigate the incidence and clinicopathological significance of INI1 loss in colorectal adenocarcinoma (CRC). Immunohistochemistry for INI1 was performed in tissue microarray (TMA) format on a well-characterized and unselected cohort of CRCs undergoing surgical resection. If staining was negative or equivocal in the TMA sections, immunohistochemistry was repeated on whole sections. Focal or widespread negative staining for INI1 was identified in whole sections from 14 (0.46%) of 3051 CRCs. In 7 (50%) of 14 negative cases, the loss of staining was focal, whereas the remainder were characterized by negative staining in all neoplastic cells in whole sections. In the cases with focal staining, loss of staining was frequently found in areas of poor differentiation. Global or focal INI1 loss was strongly associated with higher histological grade, larger tumor size and poor overall survival (P < .001). We conclude that INI1 loss occurs rarely (0.46% when screened by TMA) in CRC, where it is associated with higher grade, larger tumor size, poorer survival, mismatch repair deficiency, and BRAFV600E mutation.